| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.05 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |